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. Todd Hurst, MD,* Abhiram Prasad, MD,† J. Wells Askew III, MD,†
artho P. Sengupta, MBBS,* A. Jamil Tajik, MD*
cottsdale, Arizona; and Rochester, Minnesota
akotsubo cardiomyopathy is an important differential diagnosis of acute coronary syndrome. It is
haracterized by normal (or near-normal) coronary arteries, regional wall motion abnormalities that
xtend beyond a single coronary vascular bed, and often, a precipitating stressor. Variants of the
lassical left ventricular apical ballooning, including mid- or basal left ventricular wall motion abnor-
alities, are increasingly recognized. Takotsubo cardiomyopathy is not rare, and heightened aware-
ess of this unique cardiomyopathy likely will lead to a higher reported incidence. Diagnosis of
akotsubo cardiomyopathy has important implications for clinical management at presentation and
fterward. The long-term prognosis is generally favorable; however, a small subset has potentially
ife-threatening complications during the initial presentation. The pathophysiologic mechanism is
nknown, but catecholamine excess likely has a central role. (J Am Coll Cardiol Img 2010;3:641–9)
2010 by the American College of Cardiology Foundations
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tsdaakotsubo cardiomyopathy is a novel cardio-
yopathy that has been recently recognized
s an important consideration in the differ-
ntial diagnosis of acute coronary syndrome.
he presenting features of takotsubo cardio-
yopathy are similar to those of myocardial
schemia after acute plaque rupture, but the
haracteristic distinctions are regional wall
otion abnormalities that extend beyond a
ingle coronary vascular bed and the absence
f epicardial coronary occlusion. A preceding
motional or physical stressor is common.
lthough the acute presentation can include
ife-threatening symptoms and hemody-
amic compromise, the long-term prognosis
s more benign than that of traditional acute
oronary syndrome (1– 6). Although this car-
iomyopathy classically is described as “api-
al ballooning syndrome,” emerging data
rom the *Division of Cardiovascular Diseases, Mayo Clinic, Scot
iseases, Mayo Clinic, Rochester, Minnesota.anuscript received October 11, 2009; revised manuscript received Janhow variant forms that include isolated
asal, mid-ventricular, or apical segment in-
olvement. The pathophysiology underlying
akotsubo cardiomyopathy is not known, but
he most compelling evidence suggests a
atecholamine excess.
Takotsubo cardiomyopathy first was de-
cribed in a case series of 5 Japanese patients in
991 (7). The name of the syndrome was
oined (8) on the basis of similarities between
he appearance of the left ventricle in systole
narrow neck and wide base; Figs. 1A and 1B)
nd the shape of a Japanese octopus trap. Other
uggested names are “transient ventricular bal-
ooning syndrome,” “left ventricular apical bal-
ooning syndrome,” “stress-induced cardiomy-
pathy,” “ampulla cardiomyopathy,” and
broken heart syndrome.”
le, Arizona; and the †Division of Cardiovascularuary 14, 2010, accepted January 22, 2010.
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642linical Features
atient characteristics. Takotsubo cardiomyopathy
epresents an estimated 1% to 2% of patients who
resent with an acute coronary syndrome (1), al-
hough this estimate may be low because of under-
ecognition. The age range of patients with takot-
ubo cardiomyopathy extends from the first to the
inth decade (4), and patients are usually female
nd most commonly post-menopausal, whereas
en account for less than 10% of cases. In the first
arge Japanese series describing takotsubo cardio-
yopathy, 76 patients were women, 12 were men,
nd the median age was 67  13 years (4).
orty-three percent had a preceding acute medical
ondition (surgical procedure, cerebrovascular acci-
ent, asthma exacerbation), and 27% had a severe
motional or physical stressor. The in-hospital
ourse was complicated by pulmonary edema
22%), cardiogenic shock (15%), ventricular tachy-
ardia or fibrillation (9%), or death (1%). However,
5 of 88 patients were New York Heart Association
unctional class I at discharge, with a mean left
entricular ejection fraction that improved from
1%  11% at admission to 64%  10% at
ischarge. During a mean follow-up of 13  14
onths, 2 patients had recurrence and 1 had sudden
eath. Similar findings have been reported in sub-
equent case series from around the world, includ-
ng Europe (9) and the U.S. (1,6).
resentation. The most common presenting symp-
om is chest pain (70% to 90%). Less common
ymptoms such as dyspnea (approximately 20%)
nd pulmonary edema may occur, but cardiac arrest,
ardiogenic shock, and serious ventricular arrhyth-
ias are rare (4,6,10,11). Nonspecific symptoms
uch as syncope, weakness, cough, and fever also
ave been reported (12). An emotional, psycholog-
cal, or physical stressor (or a combination) is
ypical, although not always present (1). Commonly
eported precipitating stressors include being in-
ormed of the death of a loved one, social events
uch as public speaking or a surprise birthday party,
nd anxiety or pain related to a medical procedure
1–6,9). Other situations that are less common, but
till considered possible triggers of takotsubo car-
iomyopathy, include cocaine use (13), opiate with-
rawal (14), stress testing (15) (with dobutamine
16]), lightning strike (17), ergonovine injection
18), and thyrotoxicosis (19). A chronobiological
attern has also been reported by a multicenter
talian study, with increased frequency of presenta-Figure 1. Radiograph of the Left Ventricle
(A) Left ventriculogram in diastole. (B) Left ventriculogram in systole shows preserved contraction
of the base of the ventricle and apical ballooning. (C) Right anterior oblique view in diastole. (D)
Right anterior oblique view in systole. Note the hypercontractility of the basal and apical seg-
ments and ballooning of the mid-ventricular segments. (E) After methamphetamine use in end-
diastole. (F) After methamphetamine use in end-systole. Basal segments are akinetic, the papillary
level shows normal contractility, and the apex is hypercontractile. (G) Cardiac magnetic reso-
nance image. Hypotension may be due to dynamic outﬂow tract obstruction caused by hyperki-
nesis of the basal left ventricle segments and systolic anterior motion of the mitral valve. Four-
chamber, steady-state, free-precession image: end-diastole (left) and end-systole (center) show
left and right ventricular apical akinesis. (Right) Three-chamber image in systole shows systolic
anterior motion of the mitral leaﬂets (*) with dynamic left ventricular outﬂow tract obstruction;
left ventricular apical mass consistent with thrombus (**). Panels C and D are adapted, with per-
mission from Hurst et al. (31). Panels E and F are adapted, with permission from Reuss et al. (34).
Panel G is adapted, with permission from Syed IS, et al. (38). Apical ballooning syndrome or
aborted myocardial infarction? Insights from cardiovascular magnetic resonance imaging. Int
J Cardiovasc Imaging 2008;24:875–82. Ao  aorta; LA  left atrium; LV  left ventricle; RA ion in the summer months and in the morning
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643ours (20). As our experience and knowledge of
akotsubo cardiomyopathy has increased, the pro-
osed Mayo diagnostic criteria for the syndrome
ave evolved. Table 1 shows updated criteria (21).
Takotsubo cardiomyopathy should be considered in
he differential diagnosis of acute myocardial infarc-
ion for a post-menopausal woman who presents with
ymptoms of myocardial ischemia after acute emo-
ional or physical stress. For such patients, emergent
ransfer to a center with primary angioplasty capabil-
ties may lead to the diagnosis of takotsubo cardiomy-
pathy, thereby avoiding the administration of fi-
rinolytic therapy and the potential, subsequent
omplications. However, such transfers should only be
onsidered when transfer and angiography can be
erformed within recommended door-to-balloon
uidelines (22). Furthermore, such a strategy must not
e implemented at the expense of withholding life-
aving reperfusion therapy from patients with ST-
egment elevation myocardial infarction.
lectrocardiography, coronary angiography, and left
entriculography. Electrocardiogram findings in pa-
ients with takotsubo cardiomyopathy vary at pre-
entation. ST-segment elevation is present in ap-
roximately one-third of patients, with the anterior
eads most commonly involved (Fig. 2) (23,24).
owever, deep T-wave inversion and nonspecific
T-T wave changes may also be seen on the
lectrocardiogram at presentation. Common
hanges observed with serial electrocardiograms
nclude prolongation of the QT interval and deep,
ymmetric T-wave inversion (1,3) that may take
everal weeks or months to resolve (Fig. 2) (12,25).
espite the long QT interval, torsades de pointes
arely is reported (26,27). Individuals who present
ith ST-segment elevation have a higher likelihood
f undergoing coronary angiography, which is re-
uired for the diagnosis of takotsubo cardiomyop-
thy. Thus, the high percentage of patients with
akotsubo cardiomyopathy and ST-segment eleva-
Table 1. Proposed Mayo Clinic Criteria for Diagnosis of Takotsu
1. Transient hypokinesis, akinesis, or dyskinesis of the left ventricula
motion abnormalities extend beyond a single coronary vascular
2. No obstructive coronary disease or acute plaque rupture (determ
3. New electrocardiographic abnormalities (ST-segment elevation, T
level.
4. No pheochromocytoma or myocarditis. For such patients, the dia
a clear, stressful, precipitating event must be sought.
*A rare exception to these criteria is regional wall motion abnormality that is lim
also have takotsubo cardiomyopathy development. However, this is very rare (b
Prasad et al. (21).ion in some series may be due to selection bias. hThe absence of obstructive coronary artery dis-
ase or evidence of acute plaque rupture has been
roposed as a diagnostic criterion (23). However,
here is no reason that an individual with estab-
ished, stable coronary artery disease would not also
e at risk of having takotsubo cardiomyopathy. A
ecent case series of 97 Japanese patients with
akotsubo cardiomyopathy noted a 10% incidence
f incidental coronary artery disease (75% stenosis
f a major epicardial coronary artery) (28). Another
ase series described 7 patients with presentations
onsistent with takotsubo cardiomyopathy, and at
east 1 epicardial coronary artery with 50% or
reater stenosis (29). In our experience, severe
oronary stenosis is uncommon, and when identi-
ed in patients with takotsubo cardiomyopathy, it is
arely in a multivessel distribution (30).
Classically, the apical or mid-ventricular segments
or both) of the left ventricle are akinetic (Fig. 3).
owever, other patterns of left ventricular wall mo-
ion abnormality have been reported. Takotsubo car-
iomyopathy with mid-ventricular akinesis and apical
paring has been described (Figs. 1C and 1D) (31,32)
nd may not be uncommon. A recent report suggested
hat as many as 40% of patients with takotsubo
ardiomyopathy have a mid-ventricular variant (33).
asal akinesis with mid-ventricular and apical sparing
Figs. 1E and 1F) also has been reported (34). We
ave occasionally noted a changing pattern of wall
otion abnormality (i.e., from mid-ventricular to
pical variant) in the same patient, as have other
nvestigators (35).
ardiac biomarkers. Biomarkers of cardiac myonecro-
is generally are elevated at presentation (1–6). This is
lmost always the case for cardiac troponin. Usually,
he biomarker levels peak within 24 h after presenta-
ion, but the levels are markedly lower than would be
nticipated on the basis of the extent of wall motion
bnormalities and electrocardiogram findings. The
bsence of clinically significant myocardial necrosis
Cardiomyopathy
id segments, with or without apical involvement. Regional wall
* A preceding physical or emotional stressor is often present.
angiographically).†
e inversion, or both) or modest elevation in cardiac troponin
sis of takotsubo cardiomyopathy should be made cautiously, and
o 1 coronary territory. †A patient with obstructive coronary atherosclerosis may
on our experience and the medical literature). Adapted with permission, frombo
r m
bed.
ined
-wav
gno
ited t
asedas been confirmed in several case series in which
c
t
T
A
w
p
n
l
i
m
l
s
t
m
m
t
o
i
a
o
t
a
(
a
o
v
c
P
m
i
t
i
u
M
r
d
r
a
s
(
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 6 , 2 0 1 0
J U N E 2 0 1 0 : 6 4 1 – 9
Hurst et al.
Takotsubo Cardiomyopathy
644ardiac magnetic resonance examination has shown
he absence of gadolinium hyperenhancement (3).
reatment
cute care. Initial clinical management of patients
ith takotsubo cardiomyopathy is similar to that of
atients with acute coronary syndrome. The diag-
osis must be confirmed with coronary artery and
eft ventricular imaging. A high index of suspicion
s required because early recognition can affect
anagement; this is particularly true when fibrino-
ytic therapy is being considered for patients pre-
enting with ST-segment elevation.
Hypotension occurs frequently, and it is impor-
ant to identify the cause of hypotension to deter-
ine appropriate management. Acute pump failure
ay require intravenous pressor support, but given
he evidence of catecholamine excess in the origin
f this syndrome, mechanical support with an
ntra-aortic balloon pump may be preferred. In
ddition, hypotension may be due to dynamic
Figure 2. Longitudinal Left Ventricular Strain in Stress Cardiom
A 73-year-old woman presented with chest pain and normal corona
and end-diastolic (B) frames are diagnostic of apical ballooning syn
day 1 (C) and day 2 (D). Contracting segments are in red, akinetic a
in basal and mid-ventricular segments of the inferior wall and septu
ANT  anterior; ANT_SEPT  anterior septal; INF  inferior; LAT utflow tract obstruction caused by hyperkinesis of ohe basal left ventricular segments and systolic
nterior motion of the mitral valve (Fig. 1G)
1,36,37,38). In this situation, intravenous inotropic
gents would be contraindicated; to reduce outflow
bstruction, short-acting -blockers (39) and intra-
enous fluids could be used cautiously to decrease
ontractility and increase cavity size, respectively.
eripheral vasoconstrictors such as phenylephrine
ay be considered if -blockers and fluid admin-
stration are contraindicated or ineffective.
Arrhythmias such as atrial fibrillation, ventricular
achycardia, and ventricular fibrillation are not rare
n takotsubo cardiomyopathy and are likely attrib-
table to high levels of circulating catecholamines.
echanical complications such as left ventricular
upture are rare (40–42).
Right ventricular involvement in takotsubo car-
iomyopathy has been reported (10,43–45), and
ight ventricle involvement at presentation may be
n important predictor of adverse outcome. In a
tudy of 30 patients with takotsubo cardiomyopathy
10), right ventricular dysfunction (involving apical
athy
rteries (as determined by coronary angiography). End-systolic (A)
e. Bull’s-eye view of left ventricle shows longitudinal strain on
dyskinetic segments are in blue. Note the early appearance of red
indicating recovery of myocardial shortening strain on day 2.
ral; POST  posterior; SEPT  septal.yop
ry a
drom
nd
m,
later mid-ventricular segments [or both], similar to
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645he left ventricle) was highly associated with longer
ospitalization, severe congestive heart failure, the
se of intra-aortic balloon pumps, or performance
f cardiopulmonary resuscitation.
ubacute and long-term care. In-hospital death is
are (4,10); if it occurs, it may be attributable to the
nderlying stressor rather than to the cardiomyop-
thy itself (6,46). Only a relatively small number of
ases of takotsubo cardiomyopathy–related death
ave been reported in the literature to date. The
ncidence of sudden death caused by takotsubo
ardiomyopathy before evaluation in a hospital or
mergency department is unknown, of course, but it
as been described (47).
Complete recovery of left ventricular systolic
unction is necessary to confirm the diagnosis of
akotsubo cardiomyopathy. The recovery time var-
es and can be as short as several days or as long as
everal weeks (6). Our practice uses an empirical
pproach, treating individuals with takotsubo car-
iomyopathy as those with other causes of cardio-
yopathy (with angiotensin-converting enzyme in-
Figure 3. Short-Axis Images From a Patient With Takotsubo Car
Stress-Induced Cardiomyopathy
(A) Myocardial blood ﬂow (13N-ammonia). (B) 11C hydroxyephedrine
siently abnormal sympathetic activity. Adapted with permission fromibitors and -blockers), at least until left sentricular systolic function recovers. Left ventric-
lar thrombus (6,48) and systemic thromboembo-
ism have been reported. Anticoagulation therapy,
t least until recovery of the wall motion abnormal-
ty, should be considered for those with clinically
ignificant apical hypokinesis or akinesis that per-
ists 2 to 3 days after presentation. Systemic throm-
oembolism has been reported in takotsubo cardio-
yopathy (49).
Recurrence occurs in approximately 10% of pa-
ients (1,6). Comprehensive follow-up of 100 pa-
ients for a mean of 4.4  4.6 years at the Mayo
linic showed a recurrence rate of 11.4% (5). In
hat study, the mortality rate was 16%, which was
imilar to an age- and sex-matched local popula-
ion.
Long-term -blockade and combined - and
-blockade are attractive therapies given the puta-
ive association between takotsubo cardiomyopathy
nd a catecholamine surge. Such strategies have
een advocated if patients have no contraindica-
ions, but few trial data show efficacy of these
myopathy at 2 Days and 6 Weeks After Presentation With
sitron emission tomography shows preserved perfusion but tran-
asad et al. (54).dio
potrategies (32,50).
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646athophysiology
he pathophysiology of takotsubo cardiomyopathy
s not established but is likely multifactorial, involv-
ng the vascular, endocrine, and central nervous
ystems (51). The instigating factor for most pa-
ients is an emotional or physical stressor that
ommonly is associated with a “fight or flight”
ypersympathetic response. Most evidence suggests
major contribution from catecholamine excess and
xaggerated stimulation of the sympathetic nervous
ystem. Abraham et al. (52) described 9 cases of
akotsubo cardiomyopathy precipitated by epineph-
ine or dobutamine infusion. All morphologic vari-
nts of takotsubo cardiomyopathy (apical, mid-,
nd basal) were observed, suggesting a common
ausality of excessive sympathetic stimulation.
ittstein et al. (3) determined that norepinephrine,
pinephrine, and dopamine levels were approxi-
ately 2 to 3 times higher in patients with takot-
ubo cardiomyopathy than in patients with clini-
ally significant left ventricular dysfunction due to
cute myocardial infarction. Biopsy findings from
he same study showed mononuclear cell infiltrate
nd contraction band necrosis, which are consistent
ith catecholamine-induced myocardial injury. In a
tudy of 8 patients with takotsubo cardiomyopathy
53), myocardial scintigraphy with 123I-meta-
odobenzylguanidine showed evidence of cardiac
ympathetic hyperactivity, which improved after 3
onths. Transient abnormal cardiac sympathetic
ctivity was also shown by 11C-hydroxyephedrine
maging with positron emission tomography
Fig. 3) (54). An animal model of takotsubo car-
iomyopathy with immobilized rats showed that
he abnormal findings typically observed in electro-
ardiograms and left ventriculograms were miti-
ated by - and -blockade and partially attenuated
y estrogen (55,56). More recently, increased local
elease of catecholamines from the hearts of pa-
ients with takotsubo cardiomyopathy has been
ocumented (57).
It is difficult to ignore the similar cardiac mani-
estations of takotsubo cardiomyopathy and other
isease entities with heightened catecholamine and
ympathetic discharge such as subarachnoid hem-
rrhage (58,59) and pheochromocytoma (60,61).
nimal models of subarachnoid hemorrhage have
hown a correlation between catecholamine levels
nd the extent of myocardial damage (62). Lyon et
l. (63) recently proposed that a switch in intracel-
ular signal trafficking protects cells against pro-
poptotic effects of catecholamines but is negatively wnotropic when the 1-adrenoceptor is intensely
ctivated, thereby causing myocardial stunning
hen high levels of epinephrine are circulating. A
atecholamine-induced disorder in glucose metab-
lism has been suggested on the basis of decreased
eft ventricular apical 18F-fluorodeoxyglucose up-
ake on positron emission tomography of 15 pa-
ients with the apical variant of takotsubo cardio-
yopathy (64).
Some investigators have reported coronary mi-
rovascular dysfunction in patients with takotsubo
ardiomyopathy (1,65–69), which may either cause
r be caused by the sympathetic response. Mayo
linic investigators evaluated coronary angio-
rams of 42 consecutive patients with takotsubo
ardiomyopathy and found abnormal myocardial
erfusion in 69%, as determined by Thrombolysis
n Myocardial Infarction myocardial perfusion
rade (70).
Myocarditis as a cause of takotsubo cardiomyop-
thy is not well supported by the data. Viral titers
o not rise after the initial event (71), and biopsy
ndings are not suggestive of myocarditis (71,72).
ardiac magnetic resonance imaging of a limited
umber of patients has shown no evidence of
yocarditis or infarction (3,6).
Multivessel epicardial coronary artery spasm as a
ause of takotsubo cardiomyopathy is not strongly
upported in the literature, despite isolated reports
72,73). ST segments commonly remain elevated in
atients with takotsubo cardiomyopathy, even when
oronary angiography shows no spasm. Spontane-
us or invoked coronary artery spasm is an infre-
uent observation (12).
The reason why the cardiomyopathy predomi-
ately occurs in post-menopausal women is also
nexplained. A unifying mechanism of disease will
eed to explain why women, most commonly post-
enopausal women, are predisposed to takotsubo
ardiomyopathy development after heightened
ympathetic discharge. A deficiency in estrogen
ctivity may have a role, as suggested by the higher
ncidence in post-menopausal women and the evi-
ence of estrogen supplementation attenuating ta-
otsubo cardiomyopathy in an animal model (56).
ndothelial dysfunction may be a mechanism,
iven the influence of sex hormones on endothelial
unction (74). Interestingly, a study of 72 individ-
als (47% women) with subarachnoid hemorrhage
eported that left ventricular wall motion abnormal-
ty occurred only in women (59). Cardiac syndrome
also is most common in post-menopausal
omen, and endothelial dysfunction is thought to
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647ffect the underlying pathophysiology (75,76). A
enetic component is suggested by the observation
f takotsubo cardiomyopathy occurrence in 2 sisters
nd in a mother–daughter pair (77,78).
There is no evidence documenting different
athophysiologic mechanisms in the various mor-
hologic variants of takotsubo cardiomyopathy.
common mechanism is suggested by the find-
ng of 2 morphologic variants in the same indi-
idual (35) and the finding of multiple morpho-
ogic variants with epinephrine or dobutamine
nfusion (52).
onclusions
akotsubo cardiomyopathy is important in the
ifferential diagnosis of acute coronary syndrome. It
s characterized by normal (or near-normal) coro-
ary arteries, regional wall motion abnormalitiesdue to simultaneous multivessel cor-
onary spasms: a review of 5 cases [in Woodham R, Iskannd often, a precipitating stressor. Variants of the
lassical left ventricular apical ballooning, including
id- or basal left ventricular wall motion abnor-
alities, are increasingly recognized. Takotsubo car-
iomyopathy is not rare, and heightened awareness of
his unique cardiomyopathy likely will lead to a higher
eported incidence. Diagnosis of takotsubo cardiomy-
pathy has important implications for clinical man-
gement at presentation and afterward. The long-
erm prognosis is generally favorable; however, a small
ubset has potentially life-threatening complications
uring the initial presentation. The pathophysiologic
echanism is unknown, but catecholamine excess
ikely has a central role.
eprint requests and correspondence: Dr. R. Todd Hurst,
ivision of Cardiovascular Diseases, Mayo Clinic, 13400
ast Shea Boulevard, Scottsdale, Arizona 85259. E-mail:hat extend beyond a single coronary vascular bed, hurst.todd@mayo.edu.1
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